Tags: Drug.

LY-344545 is a research drug developed by the pharmaceutical company Eli Lilly which acts as an antagonist for the metabotropic glutamate receptor subtype mGluR5. It is an epimer of another metabotropic glutamate receptor antagonist the mGluR2/3-selective LY-341495.

LY-344545_structure.png

Loading...

This page contains content from the copyrighted Wikipedia article "LY-344545"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.